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Abstract
Background: Previously, 50% of patients with breast ductal carcinoma in situ (DCIS) had more than one nuclear grade, and
neither worst nor predominant nuclear grade was significantly associated with development of invasive carcinoma. Here, we
used image analysis in addition to histologic evaluation to determine if quantification of nuclear features could provide additional
prognostic information and hence impact prognostic assessments.
Methods: Nuclear image features were extracted from about 200 nuclei of each of 80 patients with DCIS who underwent
lumpectomy alone, and received no adjuvant systemic therapy. Nuclear images were obtained from 20 representative nuclei per
duct, from each of a group of 5 ducts, in two separate fields, for 10 ducts. Reproducibility of image analysis features was
determined, as was the ability of features to discriminate between nuclear grades. Patient information was available about clinical
factors (age and method of DCIS detection), pathologic factors (DCIS size, nuclear grade, margin size, and amount of
parenchymal involvement), and 39 image features (morphology, densitometry, and texture). The prognostic effects of these
factors and features on the development of invasive breast cancer were examined with Cox step-wise multivariate regression.
Results: Duplicate measurements were similar for 89.7% to 97.4% of assessed image features. For the pooled assessment with
~200 nuclei per patient, a discriminant function with one densitometric and two texture features was significantly (p < 0.001)
associated with nuclear grading, and provided 78.8% correct jackknifed classification of a patient's nuclear grade. In multivariate
assessments, image analysis nuclear features had significant prognostic associations (p ≤ 0.05) with the development of invasive
breast cancer. Texture (difference entropy, p < 0.001; contrast, p < 0.001; peak transition probability, p = 0.01), densitometry
(range density, p = 0.004), and measured margin (p = 0.05) were associated with development of invasive disease for the pooled
data across all ducts.
Conclusion: Image analysis provided reproducible assessments of nuclear features which quantitated differences in nuclear
grading for patients. Quantitative nuclear image features indicated prognostically significant differences in DCIS, and may
contribute additional information to prognostic assessments of which patients are likely to develop invasive disease.
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Background
Ductal carcinoma in situ (DCIS) of the breast is being
diagnosed more frequently as a result of mammographic
screening. Nuclear grade is used as a major determinant of
therapy for these patients, although assignment of a grade
is a subjective evaluation and there is inconsistent evi-
dence for prognostic importance [1-11].
In our previous study of in situ duct carcinoma [12], we
identified considerable heterogeneity of grading with
about 50% of the patients exhibiting more than one grade
(different grades in the same duct, different grades in dif-
ferent ducts in the same area, or different grades in differ-
ent areas). We attempted to incorporate this heterogeneity
by evaluating nuclear grade in terms of worst or predom-
inant grade; however, nuclear grade assessed through
either of these methods was not significantly associated
with local DCIS recurrence, or the development of inva-
sive disease. There were previously no clinical or histo-
logic factors with significant (p ≤ 0.05) univariate or
multivariate associations with the development of inva-
sive carcinoma, although this cohort had experienced an
unexpectedly high early development of invasive carci-
noma, at median 5 years follow-up, that was predomi-
nantly associated with "lumpectomy alone" (referring to
local excision alone, rather than the presence of a lump).
We hypothesized that the heterogeneity of grading con-
tributed to the lack of apparent clinical significance for
nuclear grade. A quantitative assessment of grading could
be both more reproducible and provide better prognostic
discrimination. Image analysis of nuclei allows a quanti-
tative assessment of this kind.
We present here a detailed clinical study of heterogeneity
of DCIS as determined by both histologic evaluation and
image analysis. We utilize the same DCIS patient cohort
and clinical and pathologic factors as in the previous
study by Miller, et al. [12] to provide an estimate of addi-
tional benefit from considering quantitative nuclear fea-
tures determined by image analysis. The focus of this
investigation was to examine whether image analysis fea-
tures impacted prognosis with respect to the development
of invasive breast cancer.
Methods
Patients
Women's College Hospital began the routine use of mam-
mography in the mid-1960's, establishing a breast imag-
ing expertise. This led to increased detection of more
breast DCIS at the Henrietta Banting Breast Cancer Center,
a multidisciplinary assessment center for breast diseases,
in the study period between 1979 and 1994 [12]. Analysis
of patient records from the practices of the group of teach-
ing surgeons identified 260 women who were diagnosed
as having DCIS of the breast. Study cases included had (a)
DCIS confirmed by pathology review, (b) histology slides
of the initial DCIS and most subsequent carcinomas avail-
able for review, (c) no previous breast or other malig-
nancy, and (d) a detailed follow-up to 1997 [12]. One
hundred and eighteen patients were excluded for the fol-
lowing reasons: 18 on review did not have DCIS; 100 had
previous carcinoma, and 18 had no (or limited) follow-up
or primary histologic slides were not available for review.
The data for the remaining 124 patients with DCIS
formed the basis of the previous study. These patients had
a median 5.0 years of follow-up. The focus was the 88
patients who underwent lumpectomy alone since this
group experienced most of the subsequent clinical events:
17 of 19 recurrences of DCIS, with the other 2 observed in
18 patients who underwent lumpectomy followed by
adjuvant radiotherapy, and all 19 DCIS recurrences were
ipsilateral at median interval 2.6 years, range 5.3 months
to 5.7 years; 11 of 12 developments of invasive carci-
noma, the eleven invasive cancers were 6 ipsilateral and 5
contralateral at median 1.8 years, range 9.5 months to 6.6
years. The median time for development of ipsilateral
invasive carcinoma was 1.6 years, range 9.5 months to 6.5
years. The twelfth diagnosis of invasive carcinoma in the
original DCIS series was an ipsilateral axillary lymph
node, which occurred in a patient who was initially
treated with simple mastectomy [13] and who is excluded
from these investigations. Seventy-eight of the 88 patients
(88%) were detected mammographically. None of the 88
patients received adjuvant radiotherapy or systemic ther-
apy.
The specimens were processed uniformly in a manner
consistent with standards at the time of the biopsies [12].
Specimens were fixed in 10% neutral buffered formalin.
Tissue blocks were created with uniform section thickness
of 3–4 microns. Tissue evaluated had not been examined
at previous frozen section. For mammographically
detected lesions, tissue was sampled rather than assessed
in toto, with sampling directed to the area marked by dye
instilled preoperatively and/or area marked by a needle
placed intraoperatively by a radiologist. Sampling of other
specimens was directed by the gross appearance of the
specimen. Several assessments were made to reflect size:
(a) estimate from the gross description, (b) maximum
dimension per slide, and (c) number of slides with DCIS
involvement.
The percent parenchyma involved (<10%, 10 to 50%,
>50%) was assessed to reflect the proportion of the total
parenchyma (stroma and all ducts and lobules) in the
areas on the slides containing DCIS that was occupied by
the involved ducts. Percentage parenchyma was based on
both fibrous and fatty stroma, and was determined on sec-
tions which contained DCIS. This reflected whether the
involved ducts were concentrated within the parenchymaBMC Cancer 2007, 7:174 http://www.biomedcentral.com/1471-2407/7/174
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(higher percentage) or more diffusely scattered (lower
percentage). Duct distribution tended to be uniform, and
a single categorization could be assigned to each patient.
Results were obtained by considering the maximum size
of the DCIS on any slide and the percentage of the paren-
chyma involved.
Resection margins had been painted with silver nitrate.
The shortest distance between an involved duct and resec-
tion margin was measured microscopically with an ocular
micrometer (in millimeters). The presence of an unin-
volved duct between DCIS and painted margin (reported
as cannot assess, not present, present) was also assessed.
The DCIS was classified into architectural patterns: solid,
cribriform, micropapillary, other (e.g., papillary, apo-
crine, clinging). All of the types present, the predominant
(most extensive) type present, and the type with least
architectural differentiation (solid versus all other) were
recorded. We used the results obtained by considering
predominant architecture and least architectural differen-
tiation: from previous paper [12], 51% of tumours were
solid by worst architecture, while 33% were solid by pre-
dominant architecture.
Calcifications included present (amorphous or crystal-
line) or not present. Necrosis was central confluent
(comedo) versus not: 67% of patients had necrosis[12].
DCIS was graded as 1, 2, and 3 (by the Van Nuys classifi-
cation scheme [14]. When more than one grade was
present, the worst (highest) grade was recorded, as well as
all grades present and the predominant (most extensive)
grade.
Image analysis
Good quality computer images for the purpose of image
analysis could be obtained from the archived hematoxylin
and eosin (H&E) stained slides of 80 of these patients; 3
patients did not have slides available for assessment,
while 5 had H&E stained slides which resulted in poor
quality images that were unsuitable for further evaluation.
These 80 patients are the subset considered for the current
study. Digital images of the slides of the 80 study patients
were acquired under the supervision of a breast patholo-
gist (NM).
Representative H&E stained slides for each patient were
selected that demonstrated the nuclear grading previously
observed for that patient. A maximum of 2 slides per
patient biopsy were selected. Two fields were selected so
that ducts were sufficiently concentrated to contain a min-
imum of 5 ducts per field in which the nuclear grading
was represented (either two fields in one slide, or one field
on each of 2 slides). Affected duct spaces were contiguous.
A low, 10 times, magnification was used for identification
of appropriate sampling regions, while 40 times magnifi-
cation was used for capturing images. A computer image
was acquired for each of 5 ducts in one field and this was
repeated for 5 ducts in the other field. Image features were
measured for each of approximately 20 representative
nuclei per duct, for a total of about 200 nuclei for each
patient. Thirty-nine computer image features were
extracted for each nucleus that described morphometry
(size and shape of nuclei), densitometry (amount of stain-
ing of the nuclei), and texture (arrangement of staining in
the nucleus). Images were acquired using NIH-Image soft-
ware v.1.57 written by Wayne Rasband [15]. Nuclear mor-
phologic and densitometric features were measured with
NIH-Image v.1.62b34-Arnv software. Texture features
were measured using TextureCalc v.1.1ax software written
by W.C.-C. All nuclear images were segmented by a single
person (DA). Some image feature calculations and the
merging of all nuclear image feature data to per duct, per
field and per person attribution were accomplished with
StatView v 5.01 (Brain Power, Calabasas, CA) software.
Nuclear images were segmented for image analysis with-
out knowledge of the corresponding clinical features or
pathologist's grading. Nuclei distributed throughout the
image field were segmented in order to assure a represent-
ative sample. Nuclear images that were incomplete (cut
off at the edges of the field) or overlapping were not
included. The few image fields that were indistinct or out
of focus were not used.
Image analysis features
For each nucleus, 39 features were determined in three
categories. (i) Morphometry: area, perimeter, ellipse
major axis, ellipse minor axis, ellipticity (major axis/
minor axis), shape form factor (4 × pi × area/perimeter
squared), and roundness b (4 × area/pi × ellipticity
squared) [16]. (ii) Densitometry: mean density, standard
deviation of density, modal density, minimum density,
maximum density, sum density (mean density × area,
used instead of I.O.D. of NIH-Image), range density. (iii)
Markovian texture features [17,18] were calculated from
the Markovian co-occurrence matrix of pixel densities
with a step size of 2. They were angular second moment,
contrast, correlation, variance, inverse difference
moment, sum average, sum variance (corrected from
[18]), difference average, difference variance, initial
entropy, final entropy, entropy, sum entropy, difference
entropy, coefficient of variation, peak transition probabil-
ity, diagonal variance, diagonal moment, second diagonal
moment, product moment, and triangular symmetry.
Additional texture features, calculated from the binned
histogram of pixel gray scale values, included histogram
mean, histogram variance, histogram skewness, and his-BMC Cancer 2007, 7:174 http://www.biomedcentral.com/1471-2407/7/174
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togram kurtosis. The mathematical formulae defining
these image features can be found in the cited references.
Prognostic factors
The clinical factors recorded on these patients were age (in
years) and type of presentation (mammographic, clini-
cally palpable, bloody nipple discharge). The histologic
factors previously evaluated [12] were maximum DCIS
size (cm), percentage of parenchyma involved with DCIS
(<10%, 10–50%, >50%), predominant architecture (0 –
cribriform/micropapillary/other, 1 – solid), worst archi-
tecture (0 – cribriform/micropapillary/other, 1 – solid),
nuclear grade [by the Van Nuys Classification system
worst (nuclear grade 1, 2, 3); also, predominant (nuclear
grade 1, 2, 3)], necrosis [none, confluent (comedo-like)],
calcification (none, crystalline/amorphous), measured
margin (zero margin, <1 mm, 1–5 mm, >5 mm), presence
of uninvolved intervening duct (not assessable, no, yes),
Van Nuys Prognostic Index. In addition, 39 nuclear image
features were determined for about 200 nuclei per patient.
For each patient, the image data were pooled across i) all
nuclei in a duct (10 assessments), ii) all nuclei in a field (2
assessments), and iii) all nuclei for a patient (1 assess-
ment) to yield a summary feature value [adjusted mean =
mean/(standard error of the mean)], for each of the 39
image features for nuclei of the 13 different assessments
per patient: 10 ducts, 2 fields, 1 overall. In addition, grad-
ing discriminant classification functions, that are
weighted combinations of image features, described
below in the Analysis section, were assessed as prognostic
factors.
Thirteen different assessments, corresponding to the 13
different ways of pooling the image analysis feature data,
were performed to examine the effects of DCIS heteroge-
neity on apparent associations with clinical outcome. In
other contexts, investigations have been restricted to sin-
gle ducts, fields, or pooled per person assessments with-
out an examination of replicability.
Events
A new diagnosis of breast carcinoma made more than 90
days after the initial surgery was designated as an event.
Invasive carcinoma in this group of patients occurred
about equally in both the ipsilateral and contralateral
breast which is consistent with the findings of some oth-
ers [19-21], including those for potentially lower risk
DCIS patients [21]. Using t-tests, there was no statistically
significant difference in image analysis features between
patients who developed invasive disease ipsilaterally, as
opposed to contralaterally. For these investigations, an
event was considered to be development of invasive carci-
noma whether ipsilateral or contralateral. There were no
deaths from breast cancer, or another cause, in this group
of patients over the study period.
Analyses
Statistical analyses were performed with BMDP PC
Dynamic Version 7.0 (same as BMDP-XP, Statistical Solu-
tions, Sagua, MA).
Image analysis pre-processing of data included for each
image feature and each patient, 1) Levene's tests for equal-
ity of variance between ducts and fields for each person
and between people, 2) the use of the mean/S.E.M. of
image features on a duct, field and patient basis, resulting
from indications in Levene's tests of significant evidence
against assumption of equal variances, 3) per duct, per
field, and per person grading disciminant classification
functions from forward step-wise Fisher linear discrimi-
nant analyses, using an entry p-value of p ≤ 0.05, and 4)
assessment of the correct classification by the grading dis-
criminant classification functions using jackknifed (leave-
one-out) classification of patients. Standardized coeffi-
cients for canonical variables in the discriminant function
are reported.
The histologic, clinical, and image analysis factors were
assessed with respect to whether they were associated with
the development of invasive disease. Univariate assess-
ments were with Kaplan-Meier plots and the Wilcoxon
(Peto-Prentice) test statistic. For each image feature, stand-
ard image analysis cut-points at the means of the data
were utilized after confirmation that the data were
approximately symmetric.
Multivariate assessments were with Cox forward step-wise
regressions, using the likelihood ratio criterion (~χ2
(1), p
≤ 0.05) as the test statistic to determine if a factor would
be added to the model. Since we had no knowledge of
which of the image analysis features assessed would best
reflect a patient's DCIS, or the extent to which differences
in image features might relate to prognoses, we performed
13 sets of multivariate analyses, corresponding to the 13
generations of image feature factors per patient: per 10
ducts, 2 fields, 1 pooled across 2 fields.
This study was approved by the Ethics Review Board at
Women's College Hospital, Toronto, Ontario, Canada.
Results
Patients
Archival H&E slides were satisfactory for image analysis
for the majority of this DCIS cohort. Only 5.7% (5/88)
patients had slides that were of too poor quality; three
patients did not have slides available for assessment.
Table 1 summarizes the heterogeneity of nuclear grade
assessed in the 80 patients for whom image analysis wasBMC Cancer 2007, 7:174 http://www.biomedcentral.com/1471-2407/7/174
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performed. In total, thirty-nine of the 80 (49%) patients
had more than one nuclear grade on histologic evalua-
tion. For analysis purposes, the patients were grouped two
ways by nuclear grading type: the focus of reporting by
Van Nuys classification of worst grade, except the single
patient with nuclear grade 1 was grouped with grade 2;
and, Group A (grade 1 only, grades 1 and 2, or grade 2
only), Group B (grades 1, 2, and 3, or grades 2 and 3), and
Group C (grade 3 only). This latter grouping of patients by
grade was used to reflect the heterogeneity observed.
Nuclear grade 1 could not be studied on its own since only
one patient had grade 1 only.
Image analysis
All nuclear regions of interest were segmented manually
by the same operator (DA). Reproducibility of manual
segmentation was determined by repeatedly segmenting
the same nucleus (CV = 3.4%, n = 150). In order to deter-
mine the reproducibility of extracted feature values, inde-
pendent measurements were made of the same nucleus in
images captured at different times. Ten or more nuclei,
identified from images of specimens of seven patients,
were segmented at two different times without knowledge
of the previously segmented region of interest, or of the
extracted feature values. The differences between the pairs
of measurements of the same nucleus were determined
with a two-tailed t-test. (The null hypothesis was that the
differences were equal to zero, at the 0.05 level of signifi-
cance.) The percent of feature values that were not statisti-
cally different in duplicate measurements ranged from
89.7% to 97.4% among nuclei of the seven patients. Fur-
ther, there were no statistically significant differences for
23 of the 39 feature values in 7/7 pairs of images, and 37
of 39 feature values in at least 5/7 pairs of images.
Classification of patients by image analysis
Patients were classified into two groups as shown in Table
1. These grading groups were used in the discriminant
analyses for nuclei in field 1 (80 patients), field 2 (79
patients), and overall pooled across both fields (80
patients). In each instance (field 1, field 2, and overall
across both fields), there were image features significantly
associated with the grading classifications, p < 0.001 for
each. The discriminant function for the first field included
two morphological features reflecting the size of nuclei
(perimeter and shape-form-factor) and three texture fea-
tures reflecting the arrangement of DNA in the nucleus
(sum entropy, product moment, difference average). Dis-
criminant analysis of the second field included one mor-
phological feature (perimeter) and one texture feature
(angular second moment). The pooled analyses across
both fields indicated one densitometric feature (sum den-
sity) and two texture features (diagonal moment and
product moment). Different image analysis features were
obtained for the first field, second field, and both fields.
Correct jackknifed (leave-one-out) classification of the
nuclear grading with the image features was respectively,
83.8%, 81.0% and 78.8%.
Discrimination using both fields would be most repre-
sentative for a patient. There was significant separation (p
< 0.001) by grade with factors that dealt with sum of pixel
intensities (sum density) and changes in spatial arrange-
ment (diagonal moment and product moment). The
effects of the discriminant classification function [0.9899
× (sum density) - 0.658 × (diagonal moment) - 0.43424 ×
(product moment) + 2.53292] are shown visually in Fig-
ure 1, with the distribution of patient values within each
of the two nuclear grading groups. Although the discrimi-
nant function was optimized to provide the best classifi-
cation of patients within the two grading groups, there
was considerable overlap between patients in the two
grading groups. Table 2 indicates the accuracy of image
analysis classification by nuclear grading group. Image
analysis features correctly classified 75.0% of patients in
Group A and 81.2% in Group B.
Prognostic factors
No clinical or pathologic factors were previously associ-
ated with the development of invasive disease [12]. The
addition of image analysis factors led to the associations
listed in Table 3. Image analysis derived features predom-
inate the significant factors indicated by multivariate anal-
yses although the particular factors differ among the 13
Table 2: Discriminant function classification of patients by grading 
group
Group Patients 
in group
Number of Patients 
classified into group
Percent 
correct
AB
A3 2 2 4 8 7 5 . 0
B 4 893 9 8 1 . 2
T o t a l 8 03 34 7 7 8 . 8
Table 1: Number of patients by pathologic grading type
Group
AB
Van Nuys Grade 1 1
Grade 1 only 1
Van Nuys Grade 2 31
Grades 1 and 2 8
Grade 2 only 23
Van Nuys Grade 3 48
Grades 2 and 3 29
Grades 1, 2, 3 2
Grade 3 only 17
Total by group 32 48BMC Cancer 2007, 7:174 http://www.biomedcentral.com/1471-2407/7/174
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sets of assessments (10 ducts, 2 fields, and 1 overall pool-
ing per patient). Differences were also indicated between
pooled data for the two fields (~100 nuclei/patient) and
the overall pooling across both fields (~200 nuclei). The
texture feature 'difference entropy' was the only factor
with a demonstratively consistent indication, being
included in 10 of 13 assessments and all 3 pooled models
across fields. The lack of stability in results suggested it
would be premature on the basis of these data to draw
conclusions about features, although there was definite
evidence to support the prognostic relevance of quantita-
tive image features. Nuclear grade was only significant in
the fourth assessment in field 1. The discriminant classifi-
cation function was significantly associated with the
development of invasive disease (p < 0.001) only for field
2. The partitioning of patients into three groups by heter-
ogeneity of grading similarly yielded 13 sets of factors;
however, the resulting discriminant classification func-
tion with minor ellipse axis and peak transition probabil-
ity was significantly associated with the development of
invasive disease in both the field 2 and overall pooled
assessments.
The factors indicated in the multivariate analyses of the
overall pooled data represent the best available summary
for the patients. The factors significantly associated with
the development of invasive disease were three texture
features quantifying the degree of order (difference
entropy p < 0.001), contrast (p < 0.001), and strongest
spatial relationship between pixels (peak transition prob-
ability, p = 0.01), a densitometry feature (range in pixel
intensity, range density, p = 0.004), and measured margin
[larger values associated with increased risk of developing
invasive breast cancer (p = 0.05)]. Figure 2 shows the uni-
variate Kaplan-Meier plots for the first two factors associ-
ated with development of invasive disease.
Discussion
Nuclear grading is an important component of medical
treatment decisions for DCIS. The determination of clini-
cal relevance for any system of assigning a nuclear grade is
hampered by the long follow-up time required to assess
the sequelae of DCIS recurrence, or the more serious
development of invasive breast cancer. Several different
guidelines have been proposed in the literature for assign-
ment of nuclear grade [e.g. [2,11]], however none of these
allow incorporation of heterogeneity of grade which has
been observed by others and by us [e.g. [11,12,22]], or
mixed architecture [22]. Using the Van Nuys grading sys-
tem [2,14] of worst grade, we previously found that grade
was not associated with either DCIS recurrence or devel-
opment of invasive disease [12]. Since 50% of our cohort
of DCIS patients exhibited more than one nuclear grade,
we previously attempted to evaluate heterogeneity of
grading by evaluating the significance of predominant
nuclear grade. However, we did not find that predomi-
nant grade was associated with clinical outcome. Further,
nuclear grade was not significantly associated with out-
come in the much larger series of NSABP-17 at median 8
year follow-up [6].
Description of nuclei on a continuous scale might be pref-
erable to classification into three discrete grades because it
would allow finer differentiation of patients' risk [12]. As
well, a more objective system of assigning a grade would
be preferable [23]. We therefore evaluated our patient
cohort using image analysis to measure multiple features
of many individual nuclei, and characterized heterogene-
Distribution of patients between the grading groups given in  Table 1 Figure 1
Distribution of patients between the grading groups given in 
Table 1.: A. Group A, B. Group B. The value of the discrimi-
nant function for each patient is determined by a weighted 
combination of image features significantly associated (p < 
0.001) with the characteristics of the grading groups, factors 
that dealt with sum of pixel intensities (sum density) and 
changes in spatial arrangement (diagonal moment and prod-
uct moment).
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ity within the DCIS lesion of each patient in a study
designed to reveal differences between different ducts and
different fields. The focus here was on the potentially seri-
ous sequelae of development of invasive disease in a
cohort that experienced an unusually high rate of this after
only a median 5 year follow-up. Although this early detec-
tion may in part be attributable to lack of detection of pre-
existing invasive disease, the primary assessment was by
breast disease experts with regional standards of care for
the time period of patient accrual. As well, the predomi-
nance of events occurred in patients receiving lumpec-
tomy alone, who a priori did not have as advanced DCIS;
patients were more likely to be managed with adjuvant
radiotherapy following lumpectomy, or with mastec-
Table 3: Clinical, histologic, and image analysis factors affecting development of invasive disease by image analysis assessment
Clinical, histologic, and image analysis factors by assessment
Field 1 Field 2
Factorsa P-value Factorsa P-value
Assessment 1 Assessment 6
Densitometry (Minimum density) 0.001 Texture (Difference entropy) <0.001
Texture (Histogram mean) 0.02 Morphometry (Ellipse major axis) <0.001
Texture (Angular second moment) 0.001
Assessment 2 Assessment 7
Texture (Difference entropy) 0.01 Densitometry (Mean density) 0.001
Morphometry (Ellipse minor axis) 0.03 Texture (Difference entropy) 0.001
Texture (Diagonal moment) 0.04
Assessment 3 Assessment 8
Texture (Difference entropy) 0.01 Densitometry (Ellipse minor axis) 0.01
Densitometry (Maximum density) 0.003
Morphometry (Shape form factor) 0.04
Assessment 4 Assessment 9
Texture (Sum variance) 0.003 Texture (Difference entropy) <0.001
Texture (Difference entropy) <0.001 Texture (Contrast) <0.001
Texture (Second diagonal moment) <0.001 Morphometry (Ellipse major axis) 0.001
Nuclear grade 0.001 Age 0.02
Morphometry (Ellipse major axis) 0.01 Densitometry (Range density) 0.03
Assessment 5 10
Densitometry (Minimum density) <0.001 Morphometry (Shape form factor) 0.001
Measured margin <0.001 Texture (Histogram mean) 0.02
Texture (Variance) <0.001 Texture (Difference entropy) 0.01
Texture (Histogram Mean) <0.001 Measured margin 0.05
Texture (Contrast) 0.002
Field 1 Overall Field 2 Overall
Assessment 11 Assessment 12
Densitometry (Minimum density) 0.005 Texture (Difference entropy) <0.001
Texture (Difference entropy) 0.01 Discriminant classification function <0.001
Texture (Diagonal moment) 0.04 Parenchymal involvement 0.001
Both Fields Overall – Assessment 13
Texture (Difference entropy) p < 0.001
Texture (Contrast) p < 0.001
Texture (Peak transition probability) p = 0.01
Densitometry (Range density) p = 0.004
Measured margin p = 0.05
a Factors significantly (p ≤ 0.05) associated with development of invasive disease, in the order entered into the step-wise forward Cox regression 
models.BMC Cancer 2007, 7:174 http://www.biomedcentral.com/1471-2407/7/174
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tomy, if the DCIS was larger than 1 cm (p = 0.01), grade 3
(p = 0.03 by worst grade, p = 0.01 by predominant grade),
or had confluent necrosis (p = 0.01) [12]. Only 7 of the
full DCIS cohort had treatment directed by participation
in NSABP-17 or NSABP-24. The prognostic associations of
image analysis features with early development of inva-
sive disease is important, given the previous lack of asso-
ciations with our clinical or pathologic factors.
The image features had demonstrative prognostic value,
although there were differences in the specific set of fea-
tures for each assessment (ducts, fields, and overall). At
least three conditions may have contributed to this incon-
sistency, numbers of nuclei, correlation between features,
and biologic heterogeneity between ducts/fields. First,
there were differences in the number of nuclei in each
assessment: Assessments 1 to 10 included 20 nuclei per
patient, whereas Assessments 11 and 12 had 100 nuclei
each, and Assessment 13 had 200 nuclei. Assessment 13,
with the largest number of nuclei, should provide most
representative grading on a per person basis; however,
some as yet unestablished nuclear characteristics in a het-
erogeneous DCIS may differentially affect prognosis. A
second condition that may have contributed to differ-
ences is the correlation between image features, especially
those in the same category. For instance, morphological
features, ellipse major axis, ellipse minor axis, and meas-
ures of nuclear size should be correlated unless there is
large variation in the shape of various nuclei of the same
patient. However, image analysis is still an investigational
tool, so consideration of clinical relevance for particular
factors is exploratory, and hypothesis generating. Thus,
correlated features, or groups of features, listed separately
for different assessments may have similar prognostic
value. Thirdly, the existence of heterogeneity between
nuclei within the same patient, indicated by mixed
nuclear grades, would be expected to influence the selec-
tion of image features in different fields of the same
patient. In this last context, differences in selection of
image features confirms the ability of image analysis to
detect and quantify that heterogeneity. The heterogeneity
between ducts of the same patient that was revealed in this
study provides a cautionary note for interpretation of data
from microdissection or microarray methodologies in
which a small number of samples each with only a few
cells are used to characterize a tumor, since the heteroge-
neity of a tumor in vivo may not be reflected in such small
samples [24,25].
Finally, we cannot eliminate the possibility that a more
thorough examination of the DCIS would have detected
the presence of constitutive ipsilateral invasive disease,
although ipsilateral invasive disease could as well be
related to multiple foci of tumour which cannot be per-
ceived at the time of primary therapy [6]. It is important
to note that the association of larger measured margins
with increased development of invasive disease occurred
in a clinical setting where surgeons may have attempted
wider excisions in patients perceived to have more exten-
sive disease, and hence patients were potentially more
likely to develop invasive breast cancer [12]. A recent pro-
spective study of patients with predominant grade 1 or 2,
mammographic extent less than or equal to 2.5 cm treated
with wide excision alone and either having final margins
≥ 1 cm, or a re-excision without residual DCIS, and who
were not permitted adjuvant Tamoxifen had to close
accrual due to meeting predetermined stopping rules for
Kaplan-Meier plots for the two image analysis factors signifi- cantly (p < 0.001) associated with development of invasive  disease in the multivariate assessments Figure 2
Kaplan-Meier plots for the two image analysis factors signifi-
cantly (p < 0.001) associated with development of invasive 
disease in the multivariate assessments: A. Texture (differ-
ence entropy) (p < 0.001). B. Texture (contrast) (p < 0.001).
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number of local recurrences [21]. Four of these patients
had ipsilateral invasive disease and four of the five who
developed contralateral invasive disease had this invasive
disease as their first failure; the invasive local recurrence
rate was 2.5%, 36% of our ipsilateral rate at a similar time
interval. It is important to note that like our study, the
Wong, et al study [21] did not have complete sequential
tissue processing [26].
Image analysis was used to precisely quantitate nuclear
morphometric, densitometric, and texture features. It is
noteworthy that the addition of the continuous image fea-
ture data resulted in finding factors significantly associ-
ated with the development of invasive disease [10], where
there had been none in previous work [12].
Multivariate analysis using image measurements indi-
cated a multiplicity of factors, rather than a unique set of
factors, that were associated with outcome(s). Although
the texture feature 'difference entropy' was included in 10
of 13 assessments and all three pooled over the fields, the
thirteen assessments led to thirteen distinct sets of pre-
dominantly image feature factors significantly associated
with the development of invasive breast cancer. Similarly,
there were another 13 sets of factors associated with DCIS
recurrence. Two conditions may have contributed to this,
the heterogeneity within the DCIS lesions and the preci-
sion of the image measurements that allowed detection of
the heterogeneity. The multiplicity of results represents an
ability of image analysis to quantitatively detect finer
nuclear heterogeneity than was qualitatively identified in
histologic evaluation [12].
Morphometric features of nuclear perimeter and nuclear
area of breast DCIS were found to be associated with
grade, necrosis, polarization, comedo architecture, and
tumor size, although their relationship to the develop-
ment of invasive disease was not reported [22]. Image
analysis of nuclear features has been found to provide
quantitative information that can contribute to diagnosis
and can have prognostic value for carcinomas of the
breast [27-36] and other sites [prostate, [37]; colorectal
mucosa, [38]]. The assessments here were specific to
nuclei in DCIS lesions and did not include cytoplasm or
stroma. This was possible because images of nuclei were
manually segmented. When regions outside of the nuclei
were included in the extraction of image feature values,
there were no features that were significantly associated
with DCIS recurrence or progression to invasive disease.
These results emphasize that differences detected by
image analysis that are specifically in nuclei may be
informative.
Our results must be viewed as hypothesis generating.
Larger patient populations would be desirable for con-
firmatory purposes, and delineation of relevance for par-
ticular image analysis features. However, as there is
currently no well-defined low-risk subgroup of patients
who can reasonably forego adjuvant therapy [21,39], this
should be a worthwhile exploration.
Conclusion
Our results suggest that it would be worthwhile to investi-
gate tumours for other cohorts where there is heterogene-
ity of nuclear grade. The images acquired in this study
were from archived biopsy specimens stained with hema-
toxylin and eosin (H&E). This suggests that other DCIS
cohorts, for which there are stored slides stained with
H&E and for which there is long term follow-up informa-
tion, could be used to yield valuable information.
The heterogeneity between ducts that was revealed in this
study provides a cautionary note for interpretation of data
from microdissection or microarray methodologies in
which a small number of samples with only a few cells are
used to characterize a tumor, since the heterogeneity of a
tumor in vivo may not be reflected in such small samples
[24,25].
The prognosis of patients with breast ductal carcinoma in
situ (DCIS) to develop invasive carcinoma can be
improved by adding quantitative nuclear features
obtained by image analysis to clinical factors and his-
topathological grades. Image analysis may be especially
useful in assessing patients with mixed nuclear grades.
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